| 2021-02-01 |
Radio-contrast medium exposure and Dialysis risk in patients with chronic kidney disease and congestive heart failure: A case-only study |
International Journal of Cardiology. 2021 Feb 01;324:199-204. |
 |
| 2018-12 |
Radio-sensitivity of IGFBP3 in oral squamous cell carcinoma cells |
Cancer Science. 2018 Dec;109(Suppl. 2):511. |
|
| 2012-11-13 |
Radioactive gold nanoparticles and methods of making and using them |
US8309135B2/2012-11-13 |
|
| 2013-03-14 |
Radioactive gold nanoparticles and methods of making and using them |
AU2009333387/2013-03-14 |
|
| 2015-04-08 |
Radioactive gold nanoparticles and methods of making and using them |
JP5699088/2015-04-08 |
|
| 2015-06-02 |
Radioactive gold nanoparticles and methods of making and using them |
CA2743315/2015-06-02 |
|
| 2014-11 |
Radioluminescence characterization of in situ x-ray nanodosimeters: Potential real-time monitors and modulators of external beam radiation therapy |
Applied Physics Letters. 2014 Nov;105(20):Article number 203110. |
|
| 2022-03-14 |
Radiometal-labeled chitosan microspheres as transarterial radioembolization agents against hepatocellular carcinoma |
Gels. 2022 Mar 14;8(3):Article number 180. |
|
| 2017-07 |
Radiosurgical target distance from the Root Entry Zone in the treatment of trigeminal neuralgia |
Practical Radiation Oncology. 2017 Jul;7(4):221-227. |
|
| 2019-06-10 |
Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma |
BMC Cancer. 2019 Jun 10;19:Article number 560. |
|
| 2024-10-09 |
Rainfall events and daily mortality across 645 global locations: Two stage time series analysis |
British Medical Journal. 2024 Oct 09;387:Article number e080944. |
|
| 2022-01 |
RamAp is an efflux pump regulator carried by an IncHI2 plasmid |
Antimicrobial Agents and Chemotherapy. 2022 Jan 18;66(1):Article number e01152-21. |
|
| 2020-02 |
Ramucirumab (RAM) or merestinib (MER) or placebo (PL) plus gemcitabine (GEM) and cisplatin (CIS) as first-line treatment for advanced or metastatic biliary tract cancer (BTC): A randomized, double-blind, phase II study |
Journal of Clinical Oncology. 2020 Feb;38(4):Meeting Abstract 477. |
|
| 2013-11-06 |
Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma |
PLoS ONE. 2013 Nov 6;8(11):Article number e79863. |
|
| 2006-01 |
Random walk, sequential analysis and related topics: A festschrift in honor of Yuan-Shih Chow. |
Random walk, sequential analysis and related topics: A festschrift in honor of Yuan-Shih Chow. |
|
| 2013-01 |
Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma |
Alimentary Pharmacology and Therapeutics. 2013 Jan;37(1):62-73. |
|
| 2019-10 |
Randomised phase 3 study of regorafenib in refractory advanced gastro-oesophageal cancer (AGOC) - Integrate II |
Annals of Oncology. 2019 Oct;30(Suppl. 6):137. |
|
| 2010-09 |
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients |
British Journal of Cancer. 2010 Sep;103(7):954-960. |
|
| 2004-02-26 |
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated |
British Journal of Cancer. 2004 Feb;90(2):359-365. |
|
| 2007-08 |
A randomised placebo-controlled trial of a traditional chinese herbal formula in the treatment of primary dysmenorrhoea |
PLoS ONE. 2007 Aug;2(8):Article number e719. |
|
| 2004-03 |
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer |
British Journal of Surgery. 2004 Mar;91(3):283-287. |
|
| 2019-03 |
Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients |
American Journal of Clinical Nutrition. 2019 Mar;109(3):606-614. |
|
| 2014-05 |
Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad |
Journal of Clinical Oncology. 2014 May;32(15, Suppl.):TPS4148. |
|
| 2007-06 |
A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naive non-small-cell lung cancer in Taiwan |
Lung Cancer. 2007 Jun;56(3):363-369. |
|
| 2013-06-21 |
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma |
Annals of Oncology. 2013 Jun 21;24(6):1567-1573. |
|
